Remedy Entertainment reported a 17.5% annual revenue increase to €59.5 million in 2025, though the company recorded a net loss of €13.03 million, significantly wider than the €3.60 million loss in 2024.
02
Operating profit for the full year was negative at €-14.9 million, primarily due to a €14.9 million impairment charge related to the FBC: Firebreak project and increased self-publishing expenditures.
03
The company maintains a strong balance sheet with an equity ratio of 67.4% and negative net gearing of -19.7%, despite total assets declining from €99.33 million to €87.55 million year-over-year.
04
Fourth-quarter performance was strong, with revenue rising 46.3% to €17.0 million and EBITDA reaching €3.9 million, supported by royalties from Control, Alan Wake 2, and FBC: Firebreak.
05
Remedy has set a long-term financial objective to double 2024 revenue by 2027 while achieving a 30% EBITDA margin.
06
Capitalized development costs are currently €20.2 million, with the majority of these funds allocated to the upcoming 2026 launch of CONTROL Resonant.
Insights
01
Remedy Entertainment reported a 17.5% annual revenue increase to €59.5 million in 2025, though the company recorded a net loss of €13.03 million, significantly wider than the €3.60 million loss in 2024.
02
Operating profit for the full year was negative at €-14.9 million, primarily due to a €14.9 million impairment charge related to the FBC: Firebreak project and increased self-publishing expenditures.
03
The company maintains a strong balance sheet with an equity ratio of 67.4% and negative net gearing of -19.7%, despite total assets declining from €99.33 million to €87.55 million year-over-year.
04
Fourth-quarter performance was strong, with revenue rising 46.3% to €17.0 million and EBITDA reaching €3.9 million, supported by royalties from Control, Alan Wake 2, and FBC: Firebreak.
05
Remedy has set a long-term financial objective to double 2024 revenue by 2027 while achieving a 30% EBITDA margin.
06
Capitalized development costs are currently €20.2 million, with the majority of these funds allocated to the upcoming 2026 launch of CONTROL Resonant.